Last Posted: Jan 05, 2019
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study
JF Greden et al,J Psych Research, January 3, 2019 - Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank.
Olson Janet E et al. Mayo Clinic proceedings. Innovations, quality & outcomes 2018 Dec 2(4) 352-358 - Roles of pharmacogenomics in non-anthracycline antineoplastic-induced cardiovascular toxicities: A systematic review and meta-analysis of genotypes effect.
Leong Siew Lian et al. International journal of cardiology 2018 Dec - Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network.
Herr Timothy M et al. Journal of the American Medical Informatics Association : JAMIA 2018 Dec - Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives.
Arbitrio Mariamena et al. High-throughput 2018 Dec 7(4) - Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit.
Zhou Shuqin et al. Frontiers in pharmacology 2018 91436 - Pharmacogenomics research and clinical implementation in Brazil.
Rodrigues-Soares Fernanda et al. Basic & clinical pharmacology & toxicology 2018 Dec - Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Borden Brittany A et al. Pharmacogenetics and genomics 2019 Feb 29(2) 31-38 - Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposure.
Marcath Lauren A et al. Pharmacogenomics 2018 Dec - Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials.
Bousman Chad A et al. Pharmacogenomics 2019 Jan 20(1) 37-47
.jpeg)
No hay comentarios:
Publicar un comentario